Sepracor, Inc. Announces Full Support of PhRMA's Revised Code on Interactions with Healthcare Professionals

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sepracor Inc. (Nasdaq: SEPR) today announced its intention to fully support the Pharmaceutical Research and Manufacturers of America’s (PhRMA) updated and enhanced Code on Interactions with Healthcare Professionals (PhRMA Code). The purpose of the revised PhRMA Code includes addressing interactions with respect to marketed pharmaceutical products and related pre-launch activities, and the industry’s relationships with clinical investigators and others as they relate to the clinical research process.

Back to news